← Back to Search

Other

Moisturizing Cream for Radiation Dermatitis

N/A
Waitlist Available
Research Sponsored by Entrinsic Bioscience Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Planned radiotherapy, as prescribed by the oncologist, is expected to provide a total radiation dose of up to 60 gray within the first 4 weeks of treatment
Aged over 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks

Summary

This trial will test a new moisturizer to see if it can help reduce skin redness from radiation therapy for breast cancer. Participants will use it daily during their treatment.

Who is the study for?
This trial is for adults over 18 with breast cancer who are undergoing radiation therapy, expected to receive up to 60 gray in the first 4 weeks. They must be able to follow daily skin care as per protocol and have no pre-existing skin conditions like eczema or psoriasis that could affect the study.
What is being tested?
Researchers are testing a new amino acid based moisturizing cream against standard skincare during radiation therapy. The goal is to see if this cream can better reduce skin redness from treatment. Participants will apply it daily alongside their prescribed radiotherapy.
What are the potential side effects?
Potential side effects may include local skin reactions such as increased redness, itching, or irritation at the site of application due to sensitivity towards ingredients in either the novel moisturizer or standard products used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My treatment plan includes up to 60 gray of radiation in the first 4 weeks.
Select...
I am over 18 years old.
Select...
I have breast cancer and am prescribed radiotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in Erythema

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Investigational ProductActive Control1 Intervention
Investigational product
Group II: Standard of CarePlacebo Group1 Intervention
Standard of Care

Find a Location

Who is running the clinical trial?

Entrinsic Bioscience Inc.Lead Sponsor
7 Previous Clinical Trials
702 Total Patients Enrolled
~31 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top